Paris (Reuters) – European scholarships finished mixed Wednesday after a salvo of indicators and results, in an uncertain geopolitical context.

In Paris, the CAC 40 abandoned 0.19% to 7,891.68 points, while the German Dax rose 0.22% and the British footsia is reinforced by 0.61%.

The Eurostoxx 50 index finished the session with a drop of 0.03%, while the FTSEUROFRIF 300 scored a gain of 0.34%and that the Stoxx 600 took 0.36%.

In Europe, the results of many banking groups, including Crédit Agricole which reported record results in the fourth quarter, and pharmaceutical groups like Novonordisk, animated exchanges.

Across the Atlantic, the latest figures were mixed, alphabet and AMD having notably disappointed investors.

The PMI indicators published on Wednesday in the euro zone on Wednesday confirmed the slight acceleration of activity in the block, while the American data showed that the employment markets remained robust.

The operators await Friday the monthly report on American employment, which will give more elements on the balance between supply and request in labor, while the Federal Reserve (Fed) has conditioned the continuation of its process D ‘Monetary softening to a weakening of employment.

The markets are also attentive to the risks of climbing the trade war between China and the United States.

“An agreement between the United States and China seems to be the most likely scenario, but we believe that the markets undervalue the risk of a longer trade conflict,” said ING analysts.

“The customs duties imposed on China do not have the same impact on American consumers and producers as those imposed in Canada and Mexico, which allows (Donald) Trump to take his time to discuss an agreement” .

VALUES

Renault fell 2.7% after information that his partner Nissan ended the discussions on a rapprochement with Honda. The European automotive sector fell 1.4%.

Totalnergies advanced 1.7%, the group that reported figures in the fourth quarter above expectations.

Wegovy manufacturer, Novo Nordisk, reported better than waiting in the fourth quarter, and increased by 4.5%. The European health sector has the best performance in the index, up 2.1%.

GSK announced on Wednesday planning for sales in 2025 on Wednesday between 3% and 5% and reported results for the fourth quarter better than expected, and granted 7.6%.

Valneva advanced 17%, at the top of the SBF120, after announcing on Wednesday that it had received a marketing authorization in the United Kingdom for IXCHIQ, the world’s leading vaccine against chikungunya.

A Wall Street

Wall Street hesitates at mid-session under the pressure of technological values.

At the time of the closure in Europe, exchanges on the New York Stock Exchange indicated an increase of 0.12% for the Dow Jones, against a Stable Standard & Poor’s Stable, and a decline of 0.26% for the Nasdaq Composite.

Changes

The dollar folds up, the threat of a widespread trade warning away.

The dollar fell 0.47% against a basket of reference currencies, the euro rises from 0.4% to 1.0419 dollars, and the pound sterling firms from 0.3% to 1.2517 dollars.

RATE

Yields are clearly folded back to the United States, operators hoping for a softening of Fed rates that are more marked than expected this year after the last indicators and the distance from tariff risks.

At the time of the closing in Europe, the yield of Treasury at ten years declines from 9.5 pb to 4.4181%, while the two -year title yield abandons 4.6 pb to 4.1681%.

The yield of ten years German lost 3.5 pb to 2.359%, that of the rate at two years remained stable at 2.054%.

OIL

The barrel falls back, the markets worrying about Sino-American tensions, while the figures of the American Institute of Petroleum showed an increase in crude inventories in the United States last week, suggesting erosion of demand.

The Brent fell 1.98% to $ 74.69 a barrel, the American light crude (West Texas Intermediate, WTI) weakens 2.09% to $ 71.18.

To be continued Thursday:

(Written by Corentin Chappron, edited by Kate Entringer)

Copyright © 2025 Thomson Reuters